Sutro Biopharma, Inc. (STRO) Social Stream
SUTRO BIOPHARMA INC (STRO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SUTRO BIOPHARMA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 6 | $37 | $29 | $34.2 | $4.29 | 697.2% |
| 2021-12-05 | 7 | $37 | $29 | $33.5 | $4.29 | 680.89% |
| 2022-05-09 | 7 | $37 | $29 | $32.333 | $4.29 | 653.68% |
| 2022-05-10 | 7 | $37 | $20 | $30.666 | $4.29 | 614.83% |
| 2022-05-11 | 7 | $37 | $20 | $29.833 | $4.29 | 595.41% |
| 2022-05-23 | 7 | $37 | $14 | $26.285 | $4.29 | 512.7% |
| 2022-08-10 | 7 | $37 | $16 | $26.571 | $4.29 | 519.37% |
| 2022-08-18 | 8 | $37 | $15 | $25.125 | $4.29 | 485.66% |
| 2022-11-09 | 8 | $33 | $15 | $23.125 | $4.29 | 439.04% |
| 2023-01-10 | 7 | $33 | $15 | $21 | $4.29 | 389.51% |
| 2023-01-13 | 7 | $33 | $15 | $21.571 | $4.29 | 402.82% |
| 2023-03-31 | 7 | $33 | $8 | $20.571 | $4.29 | 379.51% |
| 2023-05-16 | 8 | $25 | $8 | $18.428 | $4.29 | 329.56% |
| 2023-08-11 | 8 | $25 | $8 | $17.714 | $4.29 | 312.91% |
| 2023-09-05 | 9 | $25 | $8 | $16.571 | $4.29 | 286.27% |
| 2023-10-08 | 9 | $25 | $8 | $15.75 | $4.29 | 267.13% |
| 2023-11-15 | 10 | $25 | $8 | $15.333 | $4.29 | 257.41% |
| 2023-12-29 | 10 | $25 | $8 | $14.666 | $4.29 | 241.86% |
The Trend in the Analyst Price Target
Over the past 32 months, STRO's average price target has gone down $17.16.
Over the past 50 weeks, STRO's average upside potential has been 348.63%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-11-10 | 10 | 25 | 8 | 15.333 | 2.08 | 637.16% |
| 2023-11-27 | 10 | 25 | 8 | 14.666 | 2.28 | 543.25% |
| 2023-12-04 | 10 | 25 | 8 | 14.666 | 2.87 | 411.01% |
| 2023-12-06 | 10 | 25 | 8 | 14.666 | 3.17 | 362.65% |
| 2023-12-13 | 10 | 25 | 8 | 14.666 | 3.93 | 273.18% |
STRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 9 | 0 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 39 months, STRO's average broker recommendation rating worsened by 0.2.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SUTRO BIOPHARMA INC's upside potential (average analyst target price relative to current price) is greater than 2327.84% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, SUTRO BIOPHARMA INC's variance in analysts' estimates is lower than -1811.37% of them.
- In terms of how SUTRO BIOPHARMA INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2134.34% of that group.
- In terms of how SUTRO BIOPHARMA INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 953.11% of that group.
Stocks similar to SUTRO BIOPHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CLLS, ADAP, and VYGR.
View All Top Stocks by Price Target
Make investment decisions regarding STRO using the data that counts. Try POWR Ratings for free.